Attorneys for former Chemistry chair Charles M. Lieber said during a status conference that Lieber’s cancer diagnosis and deteriorating health call for an expedient trial.| www.thecrimson.com
Harvard professor Charles M. Lieber told the FBI in January 2020 that he “wasn’t completely transparent” in a separate interview with federal investigators two years prior, according to video of an interrogation presented in court by government prosecutors on Friday.| www.thecrimson.com
A federal grand jury indicted former Harvard chemistry chair Charles M. Lieber on two counts for making false statements to federal investigators who were examining funding he received from the Chinese government, the Department of Justice announced Tuesday.| www.thecrimson.com
Experts say the "academic espionage" case of Charles M. Lieber, the former chair of Harvard's Chemistry department, speaks volumes to souring U.S.-China relations.| www.thecrimson.com
Legal experts say recent court filings indicate University Professor Charles M. Lieber — charged with lying to federal officials investigating his funding sources and ties to China — may try to convince jurors that Lieber was swept up in the Trump administration’s broader anti-China campaign.| www.thecrimson.com
Federal authorities charged former Harvard Chemistry chair Charles M. Lieber in a superseding indictment with tax offenses for failing to report income he received from Wuhan University of Technology, the Department of Justice announced Tuesday.| www.thecrimson.com
Lieber’s arrest marked merely the latest development in an ongoing crackdown by the United States government and American universities on “academic espionage,” the process by which scientists pass academic research at American universities to foreign governments.| www.thecrimson.com
Harvard professor Charles M. Lieber was found guilty of lying to government authorities about his ties to China in federal court on Tuesday, concluding a stunning downfall for one of the country’s top chemists.| www.thecrimson.com
As former Harvard Chemistry chair Charles M. Lieber goes on trial on federal charges beginning Tuesday, law and trade experts speculated that his case’s outcome could decide the fate of the Department of Justice’s China Initiative.| www.thecrimson.com
